TLDR
- Cameco stock hit a new 52-week high of $110.16 following an $80 billion investment partnership with the US government and Brookfield Asset Management to deploy nuclear reactors across America
- The partnership will support new reactor deployment using Westinghouse technology, targeting energy needs for AI data centers
- Cameco reported Q2 2025 earnings of $0.51 per share, beating analyst estimates of $0.29, with revenue up 46.7% to $467.72 million
- The company is scheduled to release Q3 2025 earnings on November 5, with analysts expecting $0.22 per share
- Shares opened at $106.90 with a market cap of $46.54 billion, and institutional investors hold 70.21% of the stock
Cameco shares surged to a record high on Tuesday after the company announced a massive $80 billion investment partnership. The deal involves the US government and Brookfield Asset Management.
The Canadian uranium giant climbed to $110.16, marking a new 52-week peak. Trading opened Wednesday at $106.90.
The partnership aims to deploy new nuclear reactors across the United States. The reactors will use Westinghouse technology.
The deal targets the growing power demands of AI data centers. These facilities require reliable and secure energy sources.
CEO Tim Gitzel said the collaboration strengthens Cameco’s existing relationship with Brookfield. He expects the partnership to create long-term value for stakeholders.
The agreement includes profit-sharing mechanisms for all parties. These kick in once certain performance thresholds are met.
Recent Financial Performance
Cameco delivered strong earnings in its most recent quarter. The company reported $0.51 per share, crushing analyst expectations of $0.29.
Revenue hit $467.72 million for the quarter. This represents a 46.7% increase compared to the same period last year.
The results came despite falling short of some revenue estimates. Analysts had projected $819.79 million for the quarter.
The company posted a return on equity of 8.21%. Net margin stood at 14.97%.
Market Position and Investor Activity
The stock has seen substantial movement over the past year. Shares traded as low as $35.00 before the recent surge.
The 50-day moving average sits at $82.94. The 200-day moving average is $70.18.
Cameco’s market capitalization reached $46.54 billion. The company carries a P/E ratio of 122.87.
Institutional investors control 70.21% of Cameco’s outstanding shares. Several major funds increased their positions during recent quarters.
UBS Asset Management now holds 604,841 shares worth $24.9 million. The fund increased its stake by 11.9% during the first quarter.
Analyst sentiment remains positive on the stock. Fourteen analysts rate Cameco as a buy, with one strong buy rating and one hold.
Royal Bank of Canada raised its price target from $100 to $110. The firm maintains an outperform rating.
The average analyst price target stands at $89.55. This suggests analysts hadn’t anticipated the recent surge before the government partnership announcement.
Cameco is scheduled to report Q3 2025 earnings on November 5 before market open. Analysts expect earnings of $0.22 per share for the quarter.


